On Monday, Wave Life Sciences Ltd (NASDAQ: WVE) opened lower -3.55% from the last session, before settling in for the closing price of $13.51. Price fluctuations for WVE have ranged from $3.50 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 760.91% over the past five years. Company’s average yearly earnings per share was noted -107.84% at the time writing. With a float of $117.59 million, this company’s outstanding shares have now reached $148.39 million.
Let’s look at the performance matrix of the company that is accounted for 268 employees. In terms of profitability, gross margin is 16.52%, operating margin of -283.63%, and the pretax margin is -265.84%.
Wave Life Sciences Ltd (WVE) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Wave Life Sciences Ltd is 22.90%, while institutional ownership is 73.94%. The most recent insider transaction that took place on Nov 25 ’24, was worth 750,000. In this transaction President and CEO of this company sold 50,000 shares at a rate of $15.00, taking the stock ownership to the 217,351 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Officer proposed sale 50,000 for $15.00, making the entire transaction worth $750,000.
Wave Life Sciences Ltd (WVE) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -107.84% per share during the next fiscal year.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Check out the current performance indicators for Wave Life Sciences Ltd (WVE). In the past quarter, the stock posted a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 0.94 million. As of the previous 9 days, the stock’s Stochastic %D was 66.19%. Additionally, its Average True Range was 0.86.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 68.32%, which indicates a significant increase from 37.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.99% in the past 14 days, which was lower than the 130.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.24, while its 200-day Moving Average is $8.36. Nevertheless, the first resistance level for the watch stands at $13.63 in the near term. At $14.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.60. If the price goes on to break the first support level at $12.66, it is likely to go to the next support level at $12.29. Assuming the price breaks the second support level, the third support level stands at $11.69.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are currently 152,520K shares outstanding in the company with a market cap of 2.02 billion. Presently, the company’s annual sales total 113,310 K according to its annual income of -57,510 K. Last quarter, the company’s sales amounted to 19,690 K and its income totaled -32,920 K.
